Table 1.
Site | Controls | Percent |
---|---|---|
lip | 99 | 1.3% |
oral cavity | 390 | 5.2% |
esophagus | 174 | 2.3% |
stomach | 343 | 4.5% |
liver | 38 | 0.5% |
pancreas | 136 | 1.8% |
larynx | 280 | 3.7% |
soft tissue sarcoma | 101 | 1.3% |
melanoma | 458 | 6.1% |
non-melanoma skin | 1,050 | 13.9% |
prostate | 1,366 | 18.1% |
testis | 82 | 1.1% |
bladder | 972 | 12.9% |
kidney | 314 | 4.2% |
brain | 159 | 2.1% |
Hodgkin’s Disease | 52 | 0.7% |
non-Hodgkin’s lymphoma | 417 | 5.5% |
multiple myeloma | 118 | 1.6% |
leukemia | 184 | 2.4% |
other sites | 326 | 4.3% |
multiple sites | 493 | 6.5% |
Total | 7,552 | 100.0% |